90 Matching Annotations
  1. Aug 2022
  2. Apr 2022
  3. Mar 2022
  4. Feb 2022
  5. Jan 2022
  6. Dec 2021
  7. Nov 2021
  8. Oct 2021
  9. Sep 2021
    1. Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., Gallagher, E., Charlett, A., Angelis, D. D., Presanis, A. M., Dabrera, G., Koshy, C., Ash, A., Wise, E., Moore, N., … Gunson, R. (2021). Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00475-8

  10. Jul 2021
  11. Jun 2021
  12. May 2021
    1. Jarrad Hall. (2021, May 9). There’s a lot of speculation that COVID may become less virulent. This is still an old concept in the field, akin to aerosol vs droplet. In my own field it was assumed that resistance came at the expense of virulence. [Tweet]. @CdrHBiscuitIII. https://twitter.com/CdrHBiscuitIII/status/1391265635749957632

  13. Mar 2021
  14. Feb 2021
  15. Jan 2021
  16. Dec 2020
    1. Emily. J. Miller. - FDA {@FDASpox} (2020) Convalescent plasma has shown to be beneficial for 35% of patients. This risk reduction figure - shown in chart below - is from @MayoClinic data from expanded access program that was analyzed by FDAA for the emergency use authorization announced today. Twitter. Retrieved from: https://twitter.com/FDASpox/status/1297706985039835136

  17. Oct 2020
  18. Sep 2020
  19. Aug 2020
    1. Malani, A., Soman, S., Asher, S., Novosad, P., Imbert, C., Tandel, V., Agarwal, A., Alomar, A., Sarker, A., Shah, D., Shen, D., Gruber, J., Sachdeva, S., Kaiser, D., & Bettencourt, L. M. A. (2020). Adaptive Control of COVID-19 Outbreaks in India: Local, Gradual, and Trigger-based Exit Paths from Lockdown (Working Paper No. 27532; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27532

  20. Jul 2020
  21. Jun 2020
  22. May 2020
  23. Apr 2020